drug · small molecule
SYMDEKO (COPACKAGED)
updated 3mo ago/ EYE-və-KAF-tər /
by $VERX Vertex, Inc.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval286 co-mentions · 91 sources
- drugORKAMBI253 co-mentions · 91 sources
- drugKALYDECO233 co-mentions · 91 sources
- drugivacaftor233 co-mentions · 91 sources
- tagSmall Molecule143 co-mentions · 91 sources
- drugTRIKAFTA (COPACKAGED)38 co-mentions · 19 sources
- drug(ivacaftor + lumacaftor)20 co-mentions · 20 sources
- drug(elexacaftor + ivacaftor + tezacaftor) + ivacaftor19 co-mentions · 19 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 8 investigational indications.
targets
Cystic fibrosis transmembrane conductance regulator
all catalysts(0)
nothing on the calendar yet
Trials studying SYMDEKO (COPACKAGED)
- phase1Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
- phase2A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
- phase2Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion
- phase2The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor
- phase1Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets
- phase2A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele
- phase2Gut Imaging for Function & Transit in Cystic Fibrosis Study 2
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that